Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ANAFEN DIN 01938126

Status: Cancelled Post Market
Holder: BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
Molecule: KETOPROFEN

Health Canada record

Active ingredient(s)KETOPROFEN 100 MG
Dosage formSolution
RouteIntravenous; Intramuscular
SchedulePRESCRIPTION
ClassVeterinary
ATC
Original market date31-Dec-1993
Current status date15-Dec-2025
SourceHealth Canada DPD

Establishment licence of the holder

Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing KETOPROFEN

DINProductCompanyFormStrengthStatus
02534606FARMAFENBIMEDA-MTC ANIMAL HEALTH INCSolutionKETOPROFEN 100 MGMarketed
02172577KETOPROFEN SRAA PHARMA INCTablet (Extended-Release)KETOPROFEN 200 MGMarketed
02446316KETOPROFEN VMODERN VETERINARY THERAPEUTICS LLCSolutionKETOPROFEN 100 MGMarketed
00842664KETOPROFEN-EAA PHARMA INCTablet (Enteric-Coated)KETOPROFEN 100 MGMarketed
00790435KETOPROFEN-EAA PHARMA INCTablet (Enteric-Coated)KETOPROFEN 50 MGMarketed
02519801RIFENVETVIVA RICHTER GMBHSolutionKETOPROFEN 100 MGMarketed
02150999ANAFEN INJECTION 10MG/MLMERIAL CANADA INCSolutionKETOPROFEN 10 MGCancelled Post Market
02150972ANAFEN TABLETS 10MG/TABMERIAL CANADA INCTabletKETOPROFEN 10 MGCancelled Post Market
02150980ANAFEN TABLETS 20MG/TABMERIAL CANADA INCTabletKETOPROFEN 20 MGCancelled Post Market
02150964ANAFEN TABLETS 5MG/TABMERIAL CANADA INCTabletKETOPROFEN 5 MGCancelled Post Market
00790427KETOPROFENAA PHARMA INCCapsuleKETOPROFEN 50 MGDormant
02237011KETOPROFEN SUPPOSITORIESPHARMEL INCSuppositoryKETOPROFEN 100 MGCancelled Post Market
02236965KETOPROFEN SUPPOSITORIESPHARMEL INCSuppositoryKETOPROFEN 50 MGCancelled Pre Market
02084198KETOPROFEN-E ECT 100MGPRO DOC LIMITEETablet (Enteric-Coated)KETOPROFEN 100 MGCancelled Post Market
02084171KETOPROFEN-E ECT 50MGPRO DOC LIMITEETablet (Enteric-Coated)KETOPROFEN 50 MGCancelled Post Market
02210487KETOPROFEN-SR - SRT 200MGPRO DOC LIMITEETablet (Extended-Release)KETOPROFEN 200 MGCancelled Post Market
02156083NOVO-KETO SUPPOSITORIES 100MGNOVOPHARM LIMITEDSuppositoryKETOPROFEN 100 MGCancelled Post Market
01981536NOVO-KETO-EC TAB 100MGNOVOPHARM LIMITEDTablet (Enteric-Coated)KETOPROFEN 100 MGCancelled Post Market
01981528NOVO-KETO-EC TAB 50MGNOVOPHARM LIMITEDTablet (Enteric-Coated)KETOPROFEN 50 MGCancelled Post Market
02044633NU-KETOPROFEN CAP 50MGNU-PHARM INCCapsuleKETOPROFEN 50 MGCancelled Post Market
02044641NU-KETOPROFEN-E ECT 100MGNU-PHARM INCTablet (Enteric-Coated)KETOPROFEN 100 MGCancelled Post Market
02044781NU-KETOPROFEN-E ECT 50MGNU-PHARM INCTablet (Enteric-Coated)KETOPROFEN 50 MGCancelled Post Market
02165481ORAFEN - SUP RT 100MGTECHNILAB PHARMA INC.SuppositoryKETOPROFEN 100 MGCancelled Post Market
01926411ORUDIS 100AVENTIS PHARMA INCSuppositoryKETOPROFEN 100 MGCancelled Post Market
01931512ORUDIS 50AVENTIS PHARMA INCSuppositoryKETOPROFEN 50 MGCancelled Post Market
01926403ORUDIS CAP 50MGAVENTIS PHARMA INCCapsuleKETOPROFEN 50 MGCancelled Post Market
01926365ORUDIS E-100AVENTIS PHARMA INCTablet (Enteric-Coated)KETOPROFEN 100 MGCancelled Post Market
01926381ORUDIS E-50AVENTIS PHARMA INCTablet (Enteric-Coated)KETOPROFEN 50 MGCancelled Post Market
01926373ORUDIS SR-200AVENTIS PHARMA INCTablet (Extended-Release)KETOPROFEN 200 MGCancelled Post Market
01913050ORUVAIL 150AVENTIS PHARMA INCCapsule (Sustained-Release)KETOPROFEN 150 MGCancelled Post Market
01913069ORUVAIL 200AVENTIS PHARMA INCCapsule (Sustained-Release)KETOPROFEN 200 MGCancelled Post Market
02015951PMS-KETOPROFENPHARMASCIENCE INCSuppositoryKETOPROFEN 100 MGCancelled Post Market
02148773PMS-KETOPROFENPHARMASCIENCE INCSuppositoryKETOPROFEN 50 MGCancelled Post Market
02150808PMS-KETOPROFEN CAPSULESPHARMASCIENCE INCCapsuleKETOPROFEN 50 MGCancelled Post Market
02150824PMS-KETOPROFEN E-100 - ECTPHARMASCIENCE INCTablet (Enteric-Coated)KETOPROFEN 100 MGCancelled Post Market
02150816PMS-KETOPROFEN E-50 - ECT 50MGPHARMASCIENCE INCTablet (Enteric-Coated)KETOPROFEN 50 MGCancelled Post Market
00761699RHODISSANOFI-AVENTIS CANADA INCSuppositoryKETOPROFEN 100 MGCancelled Post Market
00761664RHODIS CAP 50MGRHODIAPHARM INCCapsuleKETOPROFEN 50 MGCancelled Post Market
00761680RHODIS ECSANOFI-AVENTIS CANADA INCTablet (Enteric-Coated)KETOPROFEN 100 MGCancelled Post Market
00761672RHODIS ECSANOFI-AVENTIS CANADA INCTablet (Enteric-Coated)KETOPROFEN 50 MGCancelled Post Market
02031175RHODIS SR 200MGRHODIAPHARM INCTablet (Extended-Release)KETOPROFEN 200 MGCancelled Post Market
02183099RHOVAIL 150RHODIAPHARM INCCapsule (Sustained-Release)KETOPROFEN 150 MGCancelled Post Market
02183102RHOVAIL 200RHODIAPHARM INCCapsule (Sustained-Release)KETOPROFEN 200 MGCancelled Post Market
02245967TEVA-KETOPROFENTEVA CANADA LIMITEDTabletKETOPROFEN 20 MGCancelled Post Market
02245966TEVA-KETOPROFENTEVA CANADA LIMITEDTabletKETOPROFEN 5 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
236492020-05-20New Drug Submission (NDS)MANUFACTURER NAME CHANGE
57642004-11-01New Drug Submission (NDS)
62512001-03-05New Drug Submission (NDS)

International API supply for KETOPROFEN

10 valid EDQM Certificates of Suitability from 10 holders. 10 active FDA Drug Master Files.

Request a quote for ANAFEN

How to read a Canadian DIN record